Germany's IQWiG wants all the data on assessed drugs
This article was originally published in Scrip
Executive Summary
IQWiG, Germany's health technology assessment institute, is annoyed that Pfizer has not supplied it with all the data on its antidepressant Edronax (reboxetine). The institute is now calling for new EU-wide obligations for firms to publish the results of clinical trials.